Stress and Visceral Hyperalgesia: Epigenetic Mechanisms
压力和内脏痛觉过敏:表观遗传机制
基本信息
- 批准号:8541353
- 负责人:
- 金额:$ 33.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-20 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal PainAcetylationAdrenal Cortex HormonesAffectAgonistAnimalsAreaBehaviorBindingBiological AssayBiomedical ResearchBloodCNR1 geneCOS CellsCellsChronicChronic stressClinicalColonComplexCorticosteroneDNA MethylationDNA-Protein InteractionDataEndocannabinoidsEpigenetic ProcessEsthesiaExperimental DesignsFeedbackFluorescence Resonance Energy TransferFutureGastrointestinal tract structureGene ExpressionGene SilencingGenesGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGoalsHarvestHistone AcetylationHormonesHumanHydrocortisoneHyperalgesiaIn SituIn VitroInterventionLabelLasersLinkMediatingMedicineMethodsMethylationMicroscopyMineralocorticoidsMonitorMotorMutateNeuronsNociceptionPainPain DisorderPathway interactionsPatternPerceptionPeripheralPharmaceutical PreparationsPlayPromoter RegionsProteinsPsychological StressRNARattusReagentReceptor GeneRegulationRegulatory PathwayRodentRoleSensorySignal Transduction PathwaySiteSpinal GangliaStressTRPV1 geneTestingTherapeutic InterventionTotal Internal Reflection FluorescentVisceralVisceral painWateracute stressbiological adaptation to stresscolorectal distensionexperiencehistone acetyltransferasehistone modificationhypothalamic-pituitary-adrenal axisinhibitor/antagonistnovelpromoterreceptorreceptor expressionresponsetargeted deliverytransmission process
项目摘要
DESCRIPTION (provided by applicant): Chronic stress is a well-known trigger for abdominal pain, a common yet poorly understood presentation in the clinical setting. We will examine the novel hypothesis that chronic stress activates epigenetic regulatory pathways resulting in enhanced abdominal pain (visceral hyperalgesia). Epigenetic pathways regulate gene expression by modifying the level of methylation of upstream promoter regions of genes (increased methylation decreases gene expression) and histone acetylation (increased histone acetylation enhances gene expression). Stress activates the hypothalamic- pituitary-adrenal axis resulting in increased blood levels of the hormone cortisol in humans and corticosterone (CORT) in rodents which regulate gene expression via the intracellular corticoid receptors GR and MR. Acute stress activates the anti-nociceptive endocannabinoid CB1 receptor gene expression which, in turn, inhibits the function of pro-nociceptive endovanilloid TRPV1 receptors. Chronic stress down-regulates CB1 expression and up-regulates TRPV1 expression. We propose that chronic stress will increase methylation of GR promoter sites resulting in decreased CB1 expression, and augment histone acetylation resulting in increased TRPV1 expression, culminating in visceral hyperalgesia. DNA methylation sites will be characterized using methylation-specific PCR analysis and pyrosequencing, and histone acetylation sites dissected using ChIP. We propose that chronic stress will modulate these pathways selectively in primary sensory dorsal root ganglion (DRG) neurons innervating the colon that transmit pain. Studies will be performed in DRGs obtained from chronic water-avoidance stressed rats, control rats treated with CORT in situ and control DRG explants treated with CORT in vitro. We will examine whether the formation of GR-MR and CB1-TRPV1 receptor complexes plays a role in stress-related visceral hyperalgesia in DRG neurons transfected with either dual labeled GR and MR, or CB1 and TRPV1 using FRET/TIRF microscopy. We hypothesize that visceral hyperalgesia will be linked to epigenetic mechanisms that selectively affect promoter sites for the GR, CB1 and TRPV1 receptors in nociceptive DRG neurons innervating the colon. This subpopulation will be identified using immunohistochemical markers and laser capture microscopy to harvest different subpopulations of DRG neurons in conjunction with quantitative PCR of relevant targets. Confirmation of the role of specific receptors (GR/MR) and signal transduction pathways (methylation/acetylation) to the changes observed in CB and TRP pathways will be confirmed using targeted delivery of specific agonist/antagonist drugs and gene silencing (si-RNA) reagents in situ, and correlation of these interventions with behavior, e.g. visceral motor response to colorectal distension. We believe that the proposed studies will have high impact regarding our understanding of how stress affects pain perception. Therapeutic interventions that target epigenetic mechanisms are touted as a pathway to personalized medicine in the future.
描述(由申请人提供):众所周知,慢性压力是腹痛的诱因,腹痛是临床上常见但知之甚少的表现。我们将研究一个新的假设,即慢性压力激活表观遗传调控途径,导致腹痛加剧(内脏痛觉过敏)。表观遗传途径通过改变基因上游启动子区域的甲基化水平(甲基化增加降低基因表达)和组蛋白乙酰化水平(组蛋白乙酰化增加增强基因表达)来调节基因表达。压力激活下丘脑-垂体-肾上腺轴,导致人类皮质醇激素和啮齿类动物皮质酮 (CORT) 血液水平升高,通过细胞内皮质激素受体 GR 和 MR 调节基因表达。急性应激会激活抗伤害性内源性大麻素 CB1 受体基因表达,进而抑制促伤害性内源性大麻素 TRPV1 受体的功能。慢性应激会下调 CB1 表达并上调 TRPV1 表达。我们认为,慢性应激会增加 GR 启动子位点的甲基化,导致 CB1 表达减少,并增加组蛋白乙酰化,导致 TRPV1 表达增加,最终导致内脏痛觉过敏。 DNA 甲基化位点将使用甲基化特异性 PCR 分析和焦磷酸测序进行表征,并使用 ChIP 解剖组蛋白乙酰化位点。我们认为,慢性压力将选择性地调节支配结肠传递疼痛的初级感觉背根神经节(DRG)神经元中的这些通路。研究将在从慢性避水应激大鼠、用 CORT 原位处理的对照大鼠和用 CORT 体外处理的对照 DRG 外植体获得的 DRG 中进行。我们将使用 FRET/TIRF 显微镜检查 GR-MR 和 CB1-TRPV1 受体复合物的形成是否在用双标记 GR 和 MR 或 CB1 和 TRPV1 转染的 DRG 神经元中与应激相关的内脏痛觉过敏中发挥作用。我们假设内脏痛觉过敏与表观遗传机制有关,该机制选择性地影响支配结肠的伤害性 DRG 神经元中 GR、CB1 和 TRPV1 受体的启动子位点。将使用免疫组织化学标记物和激光捕获显微镜来识别该亚群,以收获 DRG 神经元的不同亚群,并结合相关靶标的定量 PCR。将使用特定激动剂/拮抗剂药物的靶向递送和基因沉默(si-RNA)来确认特定受体(GR/MR)和信号转导途径(甲基化/乙酰化)对CB和TRP途径中观察到的变化的作用原位试剂,以及这些干预措施与行为的相关性,例如内脏运动对结直肠扩张的反应。我们相信,拟议的研究将对我们理解压力如何影响疼痛感知产生重大影响。针对表观遗传机制的治疗干预措施被吹捧为未来个性化医疗的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN W WILEY其他文献
JOHN W WILEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN W WILEY', 18)}}的其他基金
Actions of Resolvins on Intestinal Inflammation and Pain
Resolvins 对肠道炎症和疼痛的作用
- 批准号:
10370415 - 财政年份:2020
- 资助金额:
$ 33.43万 - 项目类别:
Actions of Resolvins on Intestinal Inflammation and Pain
Resolvins 对肠道炎症和疼痛的作用
- 批准号:
10597042 - 财政年份:2020
- 资助金额:
$ 33.43万 - 项目类别:
Chronic Stress and Abdominal Pain: Novel Mechanisms
慢性压力和腹痛:新机制
- 批准号:
8626396 - 财政年份:2013
- 资助金额:
$ 33.43万 - 项目类别:
Chronic Stress and Abdominal Pain: Novel Mechanisms
慢性压力和腹痛:新机制
- 批准号:
8478935 - 财政年份:2013
- 资助金额:
$ 33.43万 - 项目类别:
Chronic Stress and Abdominal Pain: Novel Mechanisms
慢性压力和腹痛:新机制
- 批准号:
8815954 - 财政年份:2013
- 资助金额:
$ 33.43万 - 项目类别:
Chronic Stress and Abdominal Pain: Novel Mechanisms
慢性压力和腹痛:新机制
- 批准号:
9020949 - 财政年份:2013
- 资助金额:
$ 33.43万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
皮质类固醇耐药性肠道GVHD的发病机制及防治
- 批准号:
10585851 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10917559 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
通过 Bromodomain 和 Extraterminal (BET) 结构域抑制靶向表观遗传调控治疗 GVHD
- 批准号:
10383705 - 财政年份:2021
- 资助金额:
$ 33.43万 - 项目类别:
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
通过 Bromodomain 和 Extraterminal (BET) 结构域抑制靶向表观遗传调控治疗 GVHD
- 批准号:
10602506 - 财政年份:2021
- 资助金额:
$ 33.43万 - 项目类别: